[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid

C32H34BClN6O5 — CID 71291602

IUPAC[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid
SMILESCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCCCNC(=O)c3cccc(B(O)O)c3)ccc2-n2c(C)nnc21
InChIInChI=1S/C32H34BClN6O5/c1-3-35-29(41)19-27-31-39-38-20(2)40(31)28-14-13-25(18-26(28)30(37-27)21-9-11-24(34)12-10-21)45-16-5-4-15-36-32(42)22-7-6-8-23(17-22)33(43)44/h6-14,17-18,27,43-44H,3-5,15-16,19H2,1-2H3,(H,35,41)(H,36,42)/t27-/m0/s1
InChIKeyIXFBYZTULZRCRQ-MHZLTWQESA-N
MW628.93 g/mol
LogP2.92
Rot. Bonds12

About [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid

[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid (PubChem CID 71291602) has the molecular formula C32H34BClN6O5 and a molecular weight of 628.93 g/mol. Its IUPAC name is [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid.

Molecular Properties

Compound Name[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid
PubChem CID71291602
Molecular FormulaC32H34BClN6O5
Molecular Weight628.93 g/mol
Exact Mass628.24
IUPAC Name[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid
SMILESCCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCCCNC(=O)c3cccc(B(O)O)c3)ccc2-n2c(C)nnc21
InChIInChI=1S/C32H34BClN6O5/c1-3-35-29(41)19-27-31-39-38-20(2)40(31)28-14-13-25(18-26(28)30(37-27)21-9-11-24(34)12-10-21)45-16-5-4-15-36-32(42)22-7-6-8-23(17-22)33(43)44/h6-14,17-18,27,43-44H,3-5,15-16,19H2,1-2H3,(H,35,41)(H,36,42)/t27-/m0/s1
InChIKeyIXFBYZTULZRCRQ-MHZLTWQESA-N
XLogP2.92
TPSA150.96 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500628.93
LogP ≤ 52.92
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid?
The IUPAC name of [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid (CID 71291602) is [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid.
What is the SMILES notation for [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid?
The canonical SMILES for [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid is CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OCCCCNC(=O)c3cccc(B(O)O)c3)ccc2-n2c(C)nnc21.
What is the InChIKey of [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid?
The InChIKey is IXFBYZTULZRCRQ-MHZLTWQESA-N. The full InChI is InChI=1S/C32H34BClN6O5/c1-3-35-29(41)19-27-31-39-38-20(2)40(31)28-14-13-25(18-26(28)30(37-27)21-9-11-24(34)12-10-21)45-16-5-4-15-36-32(42)22-7-6-8-23(17-22)33(43)44/h6-14,17-18,27,43-44H,3-5,15-16,19H2,1-2H3,(H,35,41)(H,36,42)/t27-/m0/s1.
What are the key properties of [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid?
[3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid has a molecular weight of 628.93 g/mol, XLogP of 2.92, 12 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [3-[4-[[(4S)-6-(4-chlorophenyl)-4-[2-(ethylamino)-2-oxoethyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-8-yl]oxy]butylcarbamoyl]phenyl]boronic acid is sourced from PubChem (CID 71291602), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).